Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Clinical Immunology
Published in: Journal of Clinical Immunology 5/2002

01-09-2002

Diagnostic Value of Anti-Saccharomyces cerevisiae and Antineutrophil Cytoplasmic Antibodies for Inflammatory Bowel Disease: High Prevalence in Patients with Celiac Disease

Authors: Jan G.M.C. Damoiseaux, Bas Bouten, Annick M.L.W. Linders, Jos Austen, Caroline Roozendaal, Maurice G.V.M. Russel, Pierre-Philippe Forget, Jan Willem Cohen Tervaert

Published in: Journal of Clinical Immunology | Issue 5/2002

Login to get access
Metadata
Title
Diagnostic Value of Anti-Saccharomyces cerevisiae and Antineutrophil Cytoplasmic Antibodies for Inflammatory Bowel Disease: High Prevalence in Patients with Celiac Disease
Authors
Jan G.M.C. Damoiseaux
Bas Bouten
Annick M.L.W. Linders
Jos Austen
Caroline Roozendaal
Maurice G.V.M. Russel
Pierre-Philippe Forget
Jan Willem Cohen Tervaert
Publication date
01-09-2002
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Journal of Clinical Immunology / Issue 5/2002
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1023/A:1019926121972

Other articles of this Issue 5/2002

Journal of Clinical Immunology 5/2002 Go to the issue

OriginalPaper

The Soluble Tumor Necrosis Factor Receptor I Is an Early Predictor of Local Infective Complications After Colorectal Surgery

OriginalPaper

A Primary Immunodeficiency Disorder Associated with Absence of Lymphoid Germinal Centers

Announcement

Announcement

OriginalPaper

Immunomodulatory Effects of Estrogen and Progesterone Replacement in a Nonhuman Primate Model

OriginalPaper

NK 1.1+ T Cell: A Two-Faced Lymphocyte in Immune Modulation of the IL-4/IFN-γ Paradigm

OriginalPaper

XLA Patients with BTK Splice-Site Mutations Produce Low Levels of Wild-Type BTK Transcripts
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits